The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P.M. Symmons, Mary Toporcer, Michael J. Mastrangelo

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalSeminars in Oncology
Volume37
Issue number1
DOIs
StatePublished - Feb 1 2010

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Chapman, P., Cranmer, L., Dixon, W. G., Hyrich, K. L., Patterson, J. R., Symmons, D. P. M., Toporcer, M., & Mastrangelo, M. J. (2010). The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit? Seminars in Oncology, 37(1), 11-19. https://doi.org/10.1053/j.seminoncol.2010.01.001